MS Mono may be available in the countries listed below.
Morphine sulphate pentahydrate (a derivative of Morphine) is reported as an ingredient of MS Mono in the following countries:
International Drug Name Search
Generic Name: pneumococcal 13-valent conjugate vaccine (NOO moe KOK al 13-VAY lent KON joo gate VAX een)
Brand Names: Prevnar 13
Pneumococcal disease is a serious infection caused by a bacteria. Pneumococcal bacteria can infect the sinuses and inner ear. It can also infect the lungs, blood, and brain, and these conditions can be fatal.
Pneumococcal 13-valent vaccine is used to prevent infection caused by pneumococcal bacteria. This vaccine contains 13 different types of pneumococcal bacteria.
Pneumococcal 13-valent vaccine works by exposing you to a small amount of the bacteria or a protein from the bacteria, which causes the body to develop immunity to the disease. This vaccine will not treat an active infection that has already developed in the body.
Becoming infected with pneumococcal disease (such as pneumonia or meningitis) is much more dangerous to your health than receiving this vaccine. However, like any medicine, this vaccine can cause side effects but the risk of serious side effects is extremely low.
Like any vaccine, pneumococcal 13-valent vaccine may not provide protection from disease in every person.
For children, the pneumococcal 13-valent vaccine is given in a series of shots. The first shot is usually given when the child is 2 months old. The booster shots are then given at 4 months, 6 months, and 12 to 15 months of age. Adults usually receive only one dose of the vaccine.
In a child older than 6 months who has not yet received this vaccine, the first dose can be given any time from the age of 7 months through 5 years (before the 6th birthday).
If the child is less than 1 year old at the time of the first shot, he or she will need 2 booster doses. If the child is 12 to 23 months old at the time of the first shot, he or she will need 1 booster dose. A child who is 2 years or older at the time of the first shot may need only the one shot and no booster doses.
You can still receive a vaccine if you have a minor cold. In the case of a more severe illness with a fever or any type of infection, wait until you get better before receiving this vaccine.
Becoming infected with pneumococcal disease (such as pneumonia or meningitis) is much more dangerous to your health than receiving this vaccine. However, like any medicine, this vaccine can cause side effects but the risk of serious side effects is extremely low.
Before your child receives this vaccine, tell your doctor if the child was born prematurely.
To make sure you or your child can safely receive this vaccine, tell your doctor if you or your child have any of these other conditions:
a bleeding or blood clotting disorder such as hemophilia or easy bruising; or
a weak immune system caused by disease, bone marrow transplant, or by using certain medicines or receiving cancer treatments.
You can still receive a vaccine if you have a minor cold. In the case of a more severe illness with a fever or any type of infection, wait until you get better before receiving this vaccine.
This vaccine is injected into a muscle. You will receive this injection in a doctor's office or clinic setting.
For children, the pneumococcal 13-valent vaccine is given in a series of shots. The first shot is usually given when the child is 2 months old. The booster shots are then given at 4 months, 6 months, and 12 to 15 months of age. Adults usually receive only one dose of the vaccine.
The first injection should be given no earlier than 6 weeks of age. Allow at least 2 months to pass between injections.
If your child is older than 6 months, he or she can still receive this vaccine on the following schedule:
Age 7-11 months: two injections at least 4 weeks apart, followed by a third injection after the child turns 1 year (at least 2 months after the second injection);
Age 12-23 months: two injections at least 2 months apart;
Age 24 months to 5 years (before the 6th birthday): one injection.
Your doctor may recommend treating fever and pain with an aspirin-free pain reliever such as acetaminophen (Tylenol) or ibuprofen (Motrin, Advil, and others) when the shot is given and for the next 24 hours. Follow the label directions or your doctor's instructions about how much of this medicine to give your child.
It is especially important to prevent fever from occurring in a child who has a seizure disorder such as epilepsy.
Contact your doctor if your child will miss a booster dose or gets behind schedule. The next dose should be given as soon as possible. There is no need to start over.
Be sure your child receives all recommended doses of this vaccine. If your child does not receive the full series of vaccines, he or she may not be fully protected against the disease.
An overdose of this vaccine is unlikely to occur.
Follow your doctor's instructions about any restrictions on food, beverages, or activity.
high fever (103 degrees or higher);
seizure (convulsions);
wheezing, trouble breathing;
severe stomach pain, severe vomiting or diarrhea;
easy bruising or bleeding; or
severe pain, itching, irritation, or skin changes where the shot was given.
Less serious side effects include
crying, fussiness;
headache, tired feeling;
muscle or joint pain;
drowsiness, sleeping more or less than usual;
mild redness, swelling, tenderness, or a hard lump where the shot was given;
loss of appetite, mild vomiting or diarrhea;
low fever (102 degrees or less), chills; or
mild skin rash.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report vaccine side effects to the US Department of Health and Human Services at 1-800-822-7967.
Usual Adult Dose for Pneumococcal Disease Prophylaxis:
50 years and older: 0.5 mL IM (a single dose).
Usual Pediatric Dose for Pneumococcal Disease Prophylaxis:
Infants (6 weeks to 6 months):
0.5 mL intramuscular injection administered at 2, 4, 6, and 12 to 15 months of age for 4 total doses; the first dose may be given as young as 6 weeks of age, but is typically given at 8 weeks (2 months of age); the 3 remaining doses are usually given at 4, 6, and 12 to 15 months of age. The recommended dosing interval is 4 to 8 weeks. The minimum interval between doses in children less than year of age is 4 weeks. The minimum interval between the third and fourth dose is 8 weeks.
Infants 7 to 11 months: 0.5 mL for 3 total doses; 2 doses at least 4 weeks apart, followed by a third dose at 12 to 15 months, separated from second dose by at least 8 weeks.
Children 12 to 23 months: 0.5 mL for 2 total doses, at least 8 weeks apart.
Children 24 to 59 months: Healthy children: 0.5 mL as a single dose.
Children 24 to 71 months with underlying medical conditions: ACIP recommendations: 0.5 mL for a total of 2 doses, separated by 8 weeks.
Previously vaccinated with pneumococcal 7 valent and/or pneumococcal 13 valent with a lapse in administration (ACIP recommendations):
Infants 7 to 11 months and previously received 1 or 2 doses: 0.5 mL dose at 7 to 11 months of age, followed by a second dose at least 8 weeks later at 12 to 15 months of age.
Children 12 to 23 months:
Previously received 1 dose before 12 months of age: 0.5 mL dose, followed by a second dose at least 8 weeks later.
Previously received 1 dose at 12 months of age or older: 0.5 mL dose at least 8 weeks after the most recent dose.
Previously received 2 or 3 doses before age 12 months: 0.5 mL dose at least 8 weeks after the most recent dose.
Children 24 to 59 months (healthy children with any incomplete schedule): 0.5 mL dose at least 8 weeks after the most recent dose.
Children 24 to 71 months with an underlying medical condition:
Previously received less than 3 doses: 0.5 mL dose at least 8 weeks after the most recent dose, followed by a second dose at least 8 weeks later.
Previously received 3 doses: 0.5 mL as a single dose at least 8 weeks after the most recent dose.
Previously completed vaccination series with pneumococcal 7 valent (4 doses) (ACIP recommendations):
Children 14 to 59 months: 0.5 mL as a single supplemental dose at least 8 weeks after the most recent dose.
Children 24 to 71 months with an underlying medical condition: 0.5 mL as a single supplemental dose at least 8 weeks after the most recent dose of pneumococcal 7 valent or pneumococcal 13 valent .
High risk for invasive pneumococcal disease (ACIP recommendations): Children 6 to 18 years: 0.5 mL as a single dose at least 8 weeks after the most recent dose of pneumococcal 7 valent or pneumococcal 13 valent (if applicable).
Also tell the doctor if you or your child have recently received drugs or treatments that can weaken the immune system, including:
an oral, nasal, inhaled, or injectable steroid medicine;
chemotherapy or radiation;
medications to treat psoriasis, rheumatoid arthritis, or other autoimmune disorders, such as azathioprine (Imuran), etanercept (Enbrel), leflunomide (Arava), and others; or
medicines to treat or prevent organ transplant rejection, such as basiliximab (Simulect), cyclosporine (Sandimmune, Neoral, Gengraf), muromonab CD3 (Orthoclone), mycophenolate mofetil (CellCept), sirolimus (Rapamune), or tacrolimus (Prograf).
If you are using any of these medications, you may not be able to receive the vaccine, or may need to wait until the other treatments are finished.
There may be other drugs that can interact with pneumococcal 13-valent vaccine. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
See also: pneumococcal3-valent conjugate vaccine side effects (in more detail)
Fincar 5 may be available in the countries listed below.
Finasteride is reported as an ingredient of Fincar 5 in the following countries:
International Drug Name Search
The following drugs and medications are in some way related to, or used in the treatment of STD Prophylaxis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Generic Name: probenecid (Oral route)
proe-BEN-e-sid
In the U.S.
Available Dosage Forms:
Therapeutic Class: Antigout
Probenecid is used in the treatment of chronic gout or gouty arthritis. These conditions are caused by too much uric acid in the blood. The medicine works by removing the extra uric acid from the body. Probenecid does not cure gout, but after you have been taking it for a few months it will help prevent gout attacks. This medicine will help prevent gout attacks only as long as you continue to take it.
Probenecid is also used to prevent or treat other medical problems that may occur if too much uric acid is present in the body.
Probenecid is sometimes used with certain kinds of antibiotics to make them more effective in the treatment of infections.
Probenecid is available only with your doctor's prescription.
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Probenecid has been tested in children 2 to 14 years of age for use together with antibiotics. It has not been shown to cause different side effects or problems than it does in adults. Studies on the effects of probenecid in patients with gout have been done only in adults. Gout is very rare in children.
Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults. There is no specific information comparing use of probenecid in the elderly with use in other age groups.
| Pregnancy Category | Explanation | |
|---|---|---|
| All Trimesters | B | Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate studies in pregnant women OR animal studies have shown an adverse effect, but adequate studies in pregnant women have failed to demonstrate a risk to the fetus. |
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.
Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:
This section provides information on the proper use of a number of products that contain probenecid. It may not be specific to Probalan. Please read with care.
If probenecid upsets your stomach, it may be taken with food. If this does not work, an antacid may be taken. If stomach upset (nausea, vomiting, or loss of appetite) continues, check with your doctor.
For patients taking probenecid for gout:
For patients taking probenecid for gout or to help remove uric acid from the body:
The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
If you will be taking probenecid for more than a few weeks, your doctor should check your progress at regular visits.
Before you have any medical tests, tell the person in charge that you are taking this medicine. The results of some tests may be affected by probenecid.
For diabetic patients:
For patients taking probenecid for gout or to help remove uric acid from the body:
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
Check with your doctor as soon as possible if any of the following side effects occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
See also: Probalan side effects (in more detail)
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
The following drugs and medications are in some way related to, or used in the treatment of Heterotopic Ossification, Total Hip Arthroplasty. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Hydrocortisone is reported as an ingredient of Massengill Towelette in the following countries:
International Drug Name Search
